Can we cure 50% of all multiple myeloma patients in the next five years?
Assessment of response in multiple myeloma: next steps
Which is the best combination therapy in relapsed and refractory multiple myeloma?
The clinical implications of progenitor cells in multiple myeloma
Gareth Morgan et al.
How next-generation sequencing will change the treatment of multiple myeloma